When these signals are sent to your ventricles, they may or may not cause symptoms. AFib with RVR describes a condition in which the ventricles respond by beating irregularly, causing a rapid ...

Etripamil for patients with atrial fibrillation with rapid ventricular rate (AFib-RVR) Phase 3 pivotal trial ... Important factors that could cause actual results to differ materially from those ...

Phase 3 pivotal trial in AFib-RVR expected to begin enrollment in H1 ... Important factors that could cause actual results to differ materially from those in the forward-looking statements include ...

PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)- Commercial capabilities ...